Cover Letter & Presubmission Inquiry (cc-cover-letter)
When to trigger
- Preparing the cover letter for full submission
- Considering a Cell Press presubmission inquiry to gauge fit
- Need to suggest or exclude reviewers
- Need to state exclusivity / prior-communication / preprint status
Presubmission inquiry (optional, fit-saving)
Cell Press allows a short editorial inquiry before full submission. Use it to test fit when uncertain:
- 1 short paragraph: the central finding and why it suits Cancer Cell.
- Attach the abstract/Summary and a key figure or graphical abstract.
- Ask directly whether the editors would welcome a full submission.
Cover-letter structure (full submission)
- Opening — addressed to the editor; manuscript title and that it is submitted to Cancer Cell.
- The advance in 2–3 sentences — the mechanism and the translational relevance, in plain language a broad cancer audience grasps.
- Why Cancer Cell — fit with the journal's mechanism + translational scope and interest to its readership.
- Evidence strength — note the orthogonal validation (cells + in vivo + human/patient data) that supports the claim.
- Novelty vs. closest prior work — one sentence on what is new and why now.
- Declarations — original, not under consideration elsewhere; preprint status; any prior editorial communication or transfer; related manuscripts in press.
- Reviewer suggestions / exclusions — see below.
- Close — corresponding author and contact.
Reviewers
- Suggest several genuine experts (different institutions; no recent collaborators, co-authors, mentors/mentees, or same-institution colleagues — avoid conflicts).
- Exclude direct competitors only with a brief, professional reason.
- Keep suggestions current and reachable; do not pad with marginal names.
Calibrate the pitch
- Match claims to evidence exactly as in the manuscript (no extra promises in the letter).
- Lead with the discovery; do not bury it under background.
- Keep it to roughly one page; respectful, specific, not promotional fluff.
Checklist
Anti-patterns
- Overstating impact beyond what the manuscript shows
- A generic letter that never says why Cancer Cell specifically
- Suggesting close collaborators or same-institution reviewers
- Excluding many competitors without justification (reads defensively)
- Omitting preprint or prior-communication disclosure
- A multi-page essay restating the abstract
Cover-letter pass for Cancer Cell
Use this as a second-pass capability check. First lock the cancer context, mechanism, model system, validation chain, and translational boundary; then test whether the manuscript addresses cancer-biology reviewers who expect mechanistic oncology, translational relevance, and strong multi-modal validation.
- Primary move: Make the letter a routing document: contribution, fit, compliance, conflicts, and the single reason the editor should send the paper to review.
- Decision ledger: return
claim / evidence / blocker / next edit rows so the next pass can patch the manuscript directly.
- Neighbor test: compare against Cell for broader biology, Nature Cancer for oncology breadth, Clinical Cancer Research for clinical translation; if the neighboring outlet has the stronger audience claim, recommend re-routing before polishing.
- Verification floor: before submission-ready advice, re-open
resources/official-source-map.md for volatile rules and name the one unresolved fact that could change the recommendation.
Output format
【Inquiry or full submission】which
【Advance (2–3 sentences)】...
【Why Cancer Cell】...
【Evidence strength line】orthogonal validation: ...
【Declarations】originality / preprint / prior comms
【Reviewers】suggested (conflict-free): [...]; excluded: [...]
【Length / tone】~1 page, claims match paper? Y/N
【Next step】cc-submission
Source: brycewang-stanford/Awesome-Journal-Skills → Cancer-Cell-Skills/skills/cc-cover-letter/SKILL.md
1---2name: cc-cover-letter3description: Use when drafting the cover letter (and optional presubmission inquiry) for a Cancer Cell (Cell Press) submission — framing significance, fit, novelty, and suggested/excluded reviewers. It writes the letter; it does not edit the manuscript itself.4---5
6
7# Cover Letter & Presubmission Inquiry (cc-cover-letter)
8
9## When to trigger
10
11- Preparing the cover letter for full submission
12- Considering a Cell Press **presubmission inquiry** to gauge fit
13- Need to suggest or exclude reviewers
14- Need to state exclusivity / prior-communication / preprint status
15
16## Presubmission inquiry (optional, fit-saving)
17
18Cell Press allows a short editorial inquiry before full submission. Use it to test fit when uncertain:
19
20- 1 short paragraph: the central finding and why it suits Cancer Cell.
21- Attach the abstract/Summary and a key figure or graphical abstract.
22- Ask directly whether the editors would welcome a full submission.
23
24## Cover-letter structure (full submission)
25
261. **Opening** — addressed to the editor; manuscript title and that it is submitted to Cancer Cell.
272. **The advance in 2–3 sentences** — the mechanism and the translational relevance, in plain language a broad cancer audience grasps.
283. **Why Cancer Cell** — fit with the journal's mechanism + translational scope and interest to its readership.
294. **Evidence strength** — note the orthogonal validation (cells + in vivo + human/patient data) that supports the claim.
305. **Novelty vs. closest prior work** — one sentence on what is new and why now.
316. **Declarations** — original, not under consideration elsewhere; preprint status; any prior editorial communication or transfer; related manuscripts in press.
327. **Reviewer suggestions / exclusions** — see below.
338. **Close** — corresponding author and contact.
34
35## Reviewers
36
37- **Suggest** several genuine experts (different institutions; no recent collaborators, co-authors, mentors/mentees, or same-institution colleagues — avoid conflicts).
38- **Exclude** direct competitors only with a brief, professional reason.
39- Keep suggestions current and reachable; do not pad with marginal names.
40
41## Calibrate the pitch
42
43- Match claims to evidence exactly as in the manuscript (no extra promises in the letter).
44- Lead with the discovery; do not bury it under background.
45- Keep it to roughly one page; respectful, specific, not promotional fluff.
46
47## Checklist
48
49- [ ] Title and target journal stated up front
50- [ ] Advance summarized in 2–3 plain sentences (mechanism + translational point)
51- [ ] Explicit "why Cancer Cell" fit paragraph
52- [ ] Orthogonal validation noted as evidence strength
53- [ ] Novelty vs. closest prior work stated
54- [ ] Originality / preprint / prior-communication declarations included
55- [ ] Suggested reviewers (conflict-free) and any exclusions with reasons
56- [ ] Corresponding author + contact; ~1 page; claims match the paper
57
58## Anti-patterns
59
60- Overstating impact beyond what the manuscript shows
61- A generic letter that never says why Cancer Cell specifically
62- Suggesting close collaborators or same-institution reviewers
63- Excluding many competitors without justification (reads defensively)
64- Omitting preprint or prior-communication disclosure
65- A multi-page essay restating the abstract
66
67
68## Cover-letter pass for Cancer Cell
69
70Use this as a second-pass capability check. First lock the cancer context, mechanism, model system, validation chain, and translational boundary; then test whether the manuscript addresses cancer-biology reviewers who expect mechanistic oncology, translational relevance, and strong multi-modal validation.
71
72- **Primary move:** Make the letter a routing document: contribution, fit, compliance, conflicts, and the single reason the editor should send the paper to review.
73- **Decision ledger:** return `claim / evidence / blocker / next edit` rows so the next pass can patch the manuscript directly.
74- **Neighbor test:** compare against Cell for broader biology, Nature Cancer for oncology breadth, Clinical Cancer Research for clinical translation; if the neighboring outlet has the stronger audience claim, recommend re-routing before polishing.
75- **Verification floor:** before submission-ready advice, re-open `resources/official-source-map.md` for volatile rules and name the one unresolved fact that could change the recommendation.
76
77## Output format
78
79```
80【Inquiry or full submission】which
81【Advance (2–3 sentences)】...
82【Why Cancer Cell】...
83【Evidence strength line】orthogonal validation: ...
84【Declarations】originality / preprint / prior comms
85【Reviewers】suggested (conflict-free): [...]; excluded: [...]
86【Length / tone】~1 page, claims match paper? Y/N
87【Next step】cc-submission
88```
89
90---
91
92**Source:** [`brycewang-stanford/Awesome-Journal-Skills`](https://github.com/brycewang-stanford/Awesome-Journal-Skills) → `Cancer-Cell-Skills/skills/cc-cover-letter/SKILL.md`
thedixitjain